Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed with Gemcitabine or Carboplatin in Advanced Malignant Mesothelioma
NCT00101283Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Feb 2006
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in malignant pleural mesothelioma (MPM), sponsored by Eastern Cooperative Oncology Group. Started Feb 2006; status: completed.
02
Drugs
pemetrexed
03
Conditions
malignant pleural mesothelioma (MPM)
Beyond the preview
Go deeper on NCT00101283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00101283.